| Literature DB >> 22016610 |
Abstract
The Eisenberg plot or hydrophobic moment plot methodology is one of the most frequently used methods of bioinformatics. Bioinformatics is more and more recognized as a helpful tool in Life Sciences in general, and recent developments in approaches recognizing lipid binding regions in proteins are promising in this respect. In this study a bioinformatics approach specialized in identifying lipid binding helical regions in proteins was used to obtain an Eisenberg plot. The validity of the Heliquest generated hydrophobic moment plot was checked and exemplified. This study indicates that the Eisenberg plot methodology can be transferred to another hydrophobicity scale and renders a user-friendly approach which can be utilized in routine checks in protein-lipid interaction and in protein and peptide lipid binding characterization studies. A combined approach seems to be advantageous and results in a powerful tool in the search of helical lipid-binding regions in proteins and peptides. The strength and limitations of the Eisenberg plot approach itself are discussed as well. The presented approach not only leads to a better understanding of the nature of the protein-lipid interactions but also provides a user-friendly tool for the search of lipid-binding regions in proteins and peptides.Entities:
Keywords: Eisenberg plot; Heliquest; amphitropic proteins; hydrophobic moment plot; lipid binding regions; protein-lipid interactions; transmembrane proteins
Mesh:
Substances:
Year: 2011 PMID: 22016610 PMCID: PMC3189734 DOI: 10.3390/ijms12095577
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Eisenberg plot as obtained by Heliquest generated data based on the original databases of Eisenberg and co-workers [1,2]. The originally identified Globular ( ), Surface seeking ( ) and TransMembrane (■) segments are depicted.
Representative examples of clearly identified transmembrane (M) and surface seeking (S) regions of proteins and peptides as reported in the literature in the period 1990–2010.
| Name | Sequence | < | <μ | D | Conf. | |
|---|---|---|---|---|---|---|
| RW16 | RRWRRWWRRWWRRWRR | 10 | 0.213 | 0.975 | YES | S [ |
| RL16 | RRLRRLLRRLLRRLRR | 10 | 0.006 | 0.824 | YES | S [ |
| Pbuy | FRKLFRVYSNFLRGKLKL | 6 | 0.280 | 0.650 | YES | S [ |
| Pill | KQLIRFLKRLDRNLWGLA | 4 | 0.447 | 0.633 | YES | S [ |
| Pc9k | NRLARHFRDIAGRVNQRL | 4 | 0.096 | 0.591 | YES | S [ |
| Pqc7 | LKDVEEAQQKIINIIRRL | 1 | 0.280 | 0.650 | YES | S [ |
| Pc3c | WYSEMKRNVQRLERAIEE | 0 | 0.113 | 0.615 | NO | S [ |
| Pihf | RDAKELVELFFEEIRRAL | −1 | 0.276 | 0.566 | NO | S [ |
| KL | KLLKLLLKLLKLLLKLLL | 5 | 0.953 | 0.659 | YES | S [ |
| CRAMP18 | GEKLKKIGQKIKNFFQKL | 5 | 0.164 | 0.674 | YES | S [ |
| SPLN14–27 | SLSRYAKLANRLA | 3 | 0.254 | 0.530 | YES | S [ |
| SPLN28–41 | PKLLETFLSKWIG | 1 | 0.712 | 0.596 | YES | S [ |
| Histatin 5 | SHAKRHHGYKRKFHEKHH | 5 | −0.157 | 0.263 | YES | G [ |
| PGLa | SKAGAIA | 3 | 0.398 | 0.501 | YES | S [ |
| SP-B(7–24) | YCWLCRALIKRIQAMIPK | 4 | 0.747 | 0.434 | YES | S [ |
| PC-TP196- | VPNFLKDMARACQNYLKK | 3 | 0.295 | 0.677 | YES | S [ |
| Equinatoxin II | ASLSFDILKTVLEALGNV | −1 | 0.591 | 0.458 | NO | S [ |
| KL4 | KLLLLKLLLLKLLLLKLL | 4 | 1.102 | 0.157 | YES | M [ |
| KALP23 | KKLALALALALALALALA | 2 | 0.783 | 0.154 | YES | M [ |
| WALP23 | WWLALALALALALALALA | 0 | 1.143 | 0.107 | NO | M [ |
| Glycophorin A (92–114) | ITLIIFGVMAGVIGTILLI | 0 | 1.133 | 0.213 | NO | M [ |
| TMX31 | WISFAISCFLLCVVLLGF | 0 | 1.321 | 0.216 | NO | M [ |
| MHCClassII | VLVALLLAGQATTAYFLY | 0 | 0.899 | 0.115 | NO | M [ |
This region is analyzed with a window of 11 AA in accordance to the original reference [21].
Figure 2Eisenberg plot of a number of successfully identified proteins and peptides in which Surface seeking ( ), Globular ( ) and TransMembrane (■) segments are depicted, see Table 1 for details. Examples of signal peptides (SP) (circles, black), lipid-binding peptides (LBP) (circles, blue), amphitropics (circles, green) and others (circles, orange) are depicted, see Table 2 for details.
Examples of demonstrated lipid-binding proteins and peptides, which are not always identified by the Eisenberg plot methodology. The results of using the lipid-binding discrimination factor of the Heliquest program are included.
| Name | Sequence | < | <μ | D | Conf. | |
|---|---|---|---|---|---|---|
| 1. prePhoE | KKSTLALVVMGIVASASV | 2 | 0.558 | 0.045 | Y | [ |
| 2. preLamB | RKLPLAVAVAAGVMSAQA | 2 | 0.478 | 0.157 | Y | [ |
| 3. proOmpA | KKTAIAIAVALAGFATVA | 2 | 0.569 | 0.204 | Y | [ |
| 4. prePhoA | TIALALLPLLPTPVTKAR | 2 | 0.744 | 0.197 | Y | [ |
| 5. Ovalbumin | IFYCPIAIMSALAMVTLG | 0 | 1.036 | 0.165 | N | [ |
| 6. Aurein 1.2 | GLFDIKKVASVIGGL | 1 | 0.583 | 0.326 | N | [ |
| 7. Citropin | GLFDVIKKVASVIGGL | 1 | 0.623 | 0.614 | Y | [ |
| 8. Maculatin 1.1 | GLFGVLAKVAAHVVPAIA | 1 | 0.738 | 0.408 | Y | [ |
| 9. VP1 | GTAMRILGGVI | 1 | 0.665 | 0.468 | Y | [ |
| 10. HA2 FP | FGAIAGFIENGWEGMIDG | −3 | 0.579 | 0.533 | N | [ |
| 11. AP1 | GEQGALAQFGEWL | −2 | 0.488 | 0.399 | N | [ |
| 12. SIV peptide | GVFVLGFLGFLA | 0 | 1.102 | 0.259 | N | [ |
| 13. Gaegurin 5 | LGALFKVASKVLPSVCAI | 2 | 0.749 | 0.463 | Y | [ |
| 14. PBP5 | GNFFGKIIDYIKLMFHHW | 1 | 0.768 | 0.616 | Y | [ |
| 16. Penetratin | RQIKIWFQNRRMKWKK | 7 | 0.193 | 0.327 | Y | [ |
| 17. Polyarginine-R9 | RRRRRRRRR | 9 | −1.010 | 0.146 | Y | [ |
| 18. Substance-P | RPKPQQFFGLM | 2 | 0.501 | 0.298 | Y | [ |
| 19. Dermaseptin B2 | 3 | −0.058 | 0.395 | Y | [ | |
| 20. SecA(1–21) | MLIKLLTKVFGSRNDRTL | 3 | 0.442 | 0.303 | Y | [ |
| 21. SecA(108–125) | KTLTATLPAYLNALTGKG | 2 | 0.437 | 0.352 | Y | [ |
| 22. SecA(593–614) | ALMRIFASDRVSGMMRKL | 3 | 0.425 | 0.131 | Y | [ |
| 23. SecA(865–882) | AAAAALAAQTGERKVGRN | 2 | 0.049 | 0.088 | Y | [ |
| 24. FtsY(1–18) | MAKEKKRGFFSWLGFGQK | 4 | 0.277 | 0.332 | Y | [ |
| 25. FtsY(188–208) | KPTKEGFFARLKRSLLKT | 5 | 0.198 | 0.254 | Y | [ |
| 26. Apocyt c2–21 | VEKGKKIFVQKCAQCHTV | 3 | 0.333 | 0.341 | Y | [ |
| 27. Apocyt c80–101 | AGIKKKTEREDLIAYLKK | 3 | 0.046 | 0.129 | Y | [ |
| 28. EcMinD251–269 | RPFRFIEEEKKGFLKRLF | 3 | 0.287 | 0.498 | Y | [ |
| 29. α-synuclein1–15 | MDVFMKGLSKAKEGV | 1 | 0.285 | 0.517 | Y | [ |
| 30. ARF1 | MGNIFANLFKGLFGKKEM | 2 | 0.474 | 0.400 | Y | [ |
| 31. K-segment dehydrins | EKKGIMDKIKEKLPG | 2 | 0.017 | 0.363 | Y | [ |
| 32. Kes 1p (7–29) | SSSWTSFLKSIASFNGDL | 0 | 0.500 | 0.523 | N | [ |
| 33. PBP4 | RRIPLVRFESRLYKDIYQNN | 3 | 0.331 | 0.285 | Y | [ |
| 34. KCNQ1354–372 | KVQQKQRQKHFNRQIPAA | 5 | −0.023 | 0.154 | Y | [ |
| 35. ABP280(49–71) | FTRWCNEHLKCVSKRIAN | 3 | 0.370 | 0.560 | Y | [ |
| 36. L15K7 | KLLKLLLKLLKLLLKLLLKLLK | 5 | 0.953 | 0.659 | Y | [ |
Examples of the use of a combined Heliquest discrimination factor and a Heliquest generated Eisenberg plot methodology in the identification of potential lipid-binding regions.
| Name | Sequence | < | <μ | D | Confirmed | |
|---|---|---|---|---|---|---|
| M13 coat protein: | ||||||
| 2KKSLVLKASVAVATLVPM19 | 3 | 0.559 | 0.072 | YES | [ | |
| 47YAWAMVVVIVGATIGIKL64 | 1 | 0.923 | 0.062 | NO | [ | |
| 54VIVGATIGIKLFKKFTSK71 | 4 | 0.553 | 0.288 | YES | - | |
| Ffh: | ||||||
| (P0AGD7) | 1MFDNLTDRLSRTLRNISG18 | 1 | 0.255 | 0.663 | YES | - |
| 44ALPVVREFINRVKEKAVG61 | 2 | 0.313 | 0.365 | YES | - | |
| 166QKPVDIVNAALKEAKLKF183 | 2 | 0.272 | 0.331 | YES | - | |
| 309SKVDRAQAEKLASKLKKG326 | 4 | −0.118 | 0.297 | YES | - | |
| 336EQLRQMKNMGGMASLMGK353 | 2 | 0.218 | 0.261 | YES | - | |
| 395KGSRKRRIAAGCGMQVQD412 | 4 | 0.008 | 0.140 | YES | - | |
| 415RLLKQFDDMQRMMKKMKK432 | 5 | 0.064 | 0.606 | YES | - | |
| 428KKMKKGGMAKMMRSMKGM445 | 7 | 0.039 | 0.327 | YES | - | |
| Fis1: | ||||||
| (P40515) | 35PTATIQSRFNYAWGLIKS52 | 2 | 0.514 | 0.349 | YES | [ |
| 60LGVKILTDIYKEAESRRR77 | 2 | 0.147 | 0.326 | YES | - | |
| 108RNNKQVGALKSMVEDKIQ125 | 2 | 0.023 | 0.305 | YES | - | |
| 133VVAGGVLAGAVAVASFFL150 | 0 | 0.811 | 0.145 | YES | [ |